425: Hanesbrands issues Gildan merger supplements

Hanesbrands released supplemental merger disclosures, detailed Goldman Sachs valuation ranges, addressed stockholder litigation, and confirmed a Nov. 25 special meeting to vote on the Gildan acquisition.

Summary

• Gildan to acquire all Hanesbrands shares for 0.102 Gildan common shares plus $0.80 in cash per HBI share, subject to stockholder and regulatory approvals.
• Special meeting set for November 25, 2025 at 9:00 a.m. ET; record date September 30, 2025; HBI board recommends voting FOR the merger and related proposals.
• Supplemental disclosures provided to address stockholder complaints and demand letters alleging disclosure deficiencies; HBI and Gildan deny any wrongdoing.
• Goldman Sachs standalone DCF for HBI implies $4.99–$8.14 per HBI share (WACC 9.75%–11.75%, terminal growth 0.0%–1.0%, terminal unlevered FCF ~$434 million).
• Goldman Sachs pro forma combined DCF implies consideration of $6.34–$9.94 per HBI share (WACC 9.25%–11.25%, terminal growth 2.5%–3.5%, terminal unlevered FCF ~$1.3 billion).
• Illustrative present value of future HBI standalone share price: $4.37–$7.97; pro forma combined consideration PV: $5.87–$8.70.
• Selected transactions analysis (6.0x–9.3x EV/LTM EBITDA range applied) yields an implied HBI value per share of $2.58–$7.28 using ~$2.2 billion net debt.
• Key inputs as of June 28/29, 2025: HBI debt ~$2.4 billion and cash ~$220 million; pro forma combined debt ~$4.2 billion and cash ~$306 million; HBI diluted shares ~364 million; pro forma combined diluted shares ~190 million.
• HBI NOL benefits estimated at ~$155 million through 2026 (discounted at 10.75% standalone; 10.25% combined); implied cash tax savings line item of $33 million added to projections.
• Forward-looking statements highlight risks including approvals, financing under a debt commitment letter, refinancing HBI debt, integration, synergies, market conditions, and operational execution.

Sentiment

Score: 6

Explanation: Process moving forward with board support and detailed valuation transparency; however, litigation, leverage, and closing/financing contingencies temper the outlook.

Positives

• Clear consideration terms: 0.102 Gildan shares plus $0.80 cash per HBI share.
• Board support: HBI directors continue to recommend voting FOR the merger.
• Standalone DCF valuation range ($4.99–$8.14) and combined DCF consideration range ($6.34–$9.94) provide transparent valuation context.
• Pro forma combined company modeling assumes stronger growth/terminal profile (2.5%–3.5% terminal growth; implied terminal EBITDA multiples 8.2x–12.6x).
• Supplemental disclosures aim to reduce litigation risk and avoid disruption to closing.
• NOL value recognized (~$155 million through 2026; $33 million cash tax savings item) enhances economic rationale.

Negatives

• Multiple stockholder lawsuits (Nov. 4 and Nov. 5, 2025) seek to enjoin the transaction and request damages.
• Implied value ranges include low-end outcomes below higher reference points (e.g., $2.58–$7.28 in selected transactions analysis).
• High leverage levels cited: HBI debt of approximately $2.4 billion; pro forma combined debt approximately $4.2 billion.
• Closing remains contingent on approvals and financing; potential for additional complaints or demand letters before closing.

Risks

• Timing and receipt of required approvals for both Gildan and Hanesbrands may delay or prevent closing.
• Realization, timing, and magnitude of expected run-rate synergies are uncertain.
• Integration execution risk and potential management distraction from ongoing operations.
• Potential undisclosed liabilities not identified during due diligence.
• Accuracy of combined and pro forma financial information may differ from actual results.
• Ability of Gildan to obtain financing under the Debt Commitment Letter or permanent financing; refinancing of Hanesbrands existing debt.
• Macroeconomic, financial, or geopolitical changes affecting demand and operations.
• Competitive intensity and reliance on a small number of significant customers.
• Volatility in raw material and energy costs and potential supply chain disruptions.
• Trade policy, tariffs, duties, and changes to trade agreements affecting manufacturing and distribution.
• Tax rate changes, loss of subsidies/credits, and outcomes of tax audits.
• Compliance with consumer product safety, employment, environmental, data privacy, anti-corruption, and other regulations.
• Cybersecurity and IT system risks, including AI-related developments and data breaches.
• Foreign exchange fluctuations and commodity price exposure.
• Hanesbrands ability to deleverage as anticipated and risk of intangible/goodwill impairment.
• International operations risks including political, regulatory, and tax complexities.
• Ability to attract and retain key personnel; reputational risks from labor/human rights allegations.
• Ongoing shareholder litigation and potential for additional complaints related to disclosures.

Future Outlook

Management highlights anticipated benefits from the Gildan–Hanesbrands combination, including synergies, enhanced operational scale, and financing/refinancing plans; however, completion depends on approvals, securing debt financing, and successful integration, with acknowledged macro, competitive, supply chain, and regulatory risks.

Management Comments

• The board of directors recommends that stockholders vote FOR approval of the transactions.
• Additional disclosures are being voluntarily provided to moot stockholder claims, avoid nuisance litigation, and minimize potential disruption.
• Hanesbrands and Gildan deny the allegations in the complaints and demand letters and do not admit that further disclosure was required.

Industry Context

The transaction continues consolidation in the basics and activewear apparel sector, where scale, vertically integrated supply chains, and cost efficiency are competitive advantages. The valuation reference ranges (6x–9.3x EV/LTM EBITDA) align with historical branded apparel deals and reflect a market still sensitive to demand variability, inventory normalization, and input cost volatility.

Comparison to Industry Standards

• Deal multiple context: The selected transaction set (e.g., Coach–Kate Spade at 9.3x, PVH–Tommy Hilfiger at 8.5x, Sycamore–Jones Group at 8.3x) supports a 6.0x–9.3x reference range, within which the implied HBI valuation falls.
• Terminal multiples: Combined-company terminal EBITDA multiples implied by the DCF (8.2x–12.6x) are broadly consistent with branded apparel operators with stronger growth/quality profiles (e.g., PVH historically high-single to low-double-digit EV/EBITDA in favorable markets).
• Standalone multiples: HBI standalone EV/NTM EBITDA range of 6.5x–8.5x sits near the lower-to-mid band for mass-market basics exposed to retailer concentration and input cost swings.
• Leverage: Pro forma debt (~$4.2b) implies elevated leverage versus best-in-class peers, consistent with financing-backed consolidation and requiring execution on synergy delivery and cash generation to delever.

Legal Proceedings

• John Burke v. Hanesbrands Inc., et al. filed November 4, 2025 in NY Supreme Court alleging negligent misrepresentation/concealment; seeks injunction, attorneys’ fees, and, if closed, damages.
• John Carroll v. Hanesbrands Inc., et al. filed November 5, 2025 in NY Supreme Court alleging negligent misrepresentation/concealment; seeks injunction, attorneys’ fees, and, if closed, damages.
• Hanesbrands received demand letters alleging disclosure deficiencies; additional similar complaints or letters may be received.

Stakeholder Impact

• Shareholders: Will receive 0.102 Gildan shares plus $0.80 cash per HBI share if the deal closes; vote scheduled for November 25, 2025.
• Employees: Potential integration and restructuring as part of synergy realization post-closing.
• Creditors: Anticipated refinancing of Hanesbrands existing debt upon closing.
• Customers and suppliers: Possible changes in purchasing, manufacturing, and distribution due to combined scale and operational integration.
• Litigation risk: Ongoing lawsuits could seek to delay closing or increase legal costs, though supplemental disclosures aim to mitigate.

Next Steps

• Hold special meeting on November 25, 2025, for Hanesbrands stockholder vote.
• Obtain remaining regulatory and corporate approvals required to close.
• Secure financing contemplated by the Debt Commitment Letter and finalize refinancing of Hanesbrands existing debt.
• If approved, proceed with integration planning and synergy execution.
• Post-closing, Gildan to conduct a strategic alternatives review for Hanesbrands Australia business.

Key Dates

Recommendation

The announcement advances the merger process and adds valuation transparency but does not change consideration terms; closing remains contingent on approvals and financing amid ongoing litigation and elevated leverage. A hold stance is appropriate pending the stockholder vote and final regulatory/financing outcomes.

Keywords

Hanesbrands, Gildan, merger, proxy statement, Form 8-K, Rule 425, special meeting, exchange ratio, cash consideration, discounted cash flow, EV/EBITDA, synergies, NOL, debt refinancing, litigation, F-4 registration, valuation analysis, WACC, terminal growth